NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/07/2026
Back to search
Official data from USPTO
KRIYA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
07/07/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
02/18/2022
Registration date
07/07/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/07/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/27/2023
First use in commerce
10/27/2023
Drawing code
4
Owner type
03
Owner location
Morrisville, NC, US
Examiner
IN, SUNG HYUN
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Kriya Therapeutics, Inc
Kriya Therapeutics, Inc
Representatives
Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseasescancerinfectious diseasesmetabolicendocrineophthalmicmusculoskeletalcardiovascularhepatologicalneurologicalhormonalimmune system related diseases and disorders; biochemical preparations for use in medical industrybiochemical preparations for the treatment of ophthalmic-related diseases
Class 42
Testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseasescancerinfectious diseasesmetabolicendocrineophthalmiconcologicalmusculoskeletalcardiovascularcardiopulmonarygenitourinaryhepatologicalrespiratoryviralneurologicalgastrointestinalhormonaldermatologicalimmune system related diseases and disorders
Publications
History of USPTO decisions and trademark events.
53 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/15/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/15/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/21/2026
IUAF
USE AMENDMENT FILED
05/11/2026
EISU
TEAS STATEMENT OF USE RECEIVED
05/11/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/20/2026
EX5G
SOU EXTENSION 5 GRANTED
01/19/2026
EEXT
SOU TEAS EXTENSION RECEIVED
11/06/2025
EXT5
SOU EXTENSION 5 FILED
11/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/01/2025
EX4G
SOU EXTENSION 4 GRANTED
05/01/2025
EXT4
SOU EXTENSION 4 FILED
04/30/2025
EEXT
SOU TEAS EXTENSION RECEIVED
04/30/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/31/2024
EX3G
SOU EXTENSION 3 GRANTED
10/31/2024
EXT3
SOU EXTENSION 3 FILED
10/31/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/31/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/30/2024
EX2G
SOU EXTENSION 2 GRANTED
04/29/2024
EXT2
SOU EXTENSION 2 FILED
04/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
04/29/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/23/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/23/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/23/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/23/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/23/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/03/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/03/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
02/01/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/11/2023
EX1G
SOU EXTENSION 1 GRANTED
11/09/2023
EXT1
SOU EXTENSION 1 FILED
11/09/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/09/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/09/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2023
PUBO
PUBLISHED FOR OPPOSITION
03/14/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/10/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/01/2023
DOCK
ASSIGNED TO EXAMINER
02/01/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/01/2022
GNRT
NON-FINAL ACTION E-MAILED
08/01/2022
CNRT
NON-FINAL ACTION WRITTEN
08/01/2022
DOCK
ASSIGNED TO EXAMINER
07/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2022
NWAP
NEW APPLICATION ENTERED
02/22/2022
Continuous trademark protection
Get notified about every new filing that threatens KRIYA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.